ResMedvs.Stryker
RMD vs SYK · both in Medtech & devices, part of the Medicine, pharma & life science value chain: Medical equipment and devices — from surgery and cardiology to robotics.
Stryker is about 4.3× larger than ResMed by market cap; ResMed trades at the lower P/E (19.6 vs 38.0); year to date, Stryker leads (−6.2% vs −15.4%).
Side by side
| RMD | SYK | |
|---|---|---|
| Market cap | $29.8B | $127B |
| Price | $203.87 | $329.78 |
| Today | −2.2% | +0.8% |
| Return YTD | −15.4% | −6.2% |
| Return 1Y | −21.0% | −16.5% |
| P/E | 19.6 | 38.0 |
| P/S | 5.4 | 5.0 |
| P/B | 4.6 | 5.5 |
Data as of 2026-07-11 · updates daily after U.S. close
The two companies
StrykerSYK
American medtech company focused on orthopaedics, surgical equipment and robot-assisted surgery (Mako).
Full SYK profile →More comparisons in Medtech & devices
See where RMD and SYK sit in the full Medicine, pharma & life science map — every segment from suppliers to end markets.Open the Life science value chain →